Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization
Open Access
- 14 December 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 67 (2), 434-435
- https://doi.org/10.1093/clinchem/hvaa278
Abstract
To the Editor:Keywords
This publication has 1 reference indexed in Scilit:
- US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2Emerging Infectious Diseases, 2020